
Galapagos NV GLPG
$ 28.82
-1.17%
Annual report 2025
added 04-04-2026
Galapagos NV P/CF Ratio 2011-2026 | GLPG
Annual P/CF Ratio Galapagos NV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -8.78 | -15.9 | 0.004 | -37.5 | -39.8 | 259 | -14.4 | -7.88 | -95.4 | 11.4 | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 259 | -95.4 | 5.04 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.88 | 3.89 % | $ 9.34 B | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
77.9 | $ 323.46 | -2.98 % | $ 42.4 B | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 4.7 | -0.63 % | $ 766 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Cabaletta Bio
CABA
|
-2.16 | $ 3.55 | 4.26 % | $ 357 M | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
-0.799 | $ 8.1 | 9.16 % | $ 80.1 M | ||
|
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
-9.8 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
8 | $ 21.91 | 1.04 % | $ 1.02 B | ||
|
CymaBay Therapeutics
CBAY
|
-47.3 | - | - | $ 3.45 B | ||
|
BioNTech SE
BNTX
|
70.7 | $ 101.31 | 1.85 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 3.07 | -3.15 % | $ 5.05 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Galectin Therapeutics
GALT
|
-7.47 | $ 2.3 | -10.35 % | $ 147 M | ||
|
ContraFect Corporation
CFRX
|
-0.0235 | - | -5.16 % | $ 5.39 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
4.92 | $ 1.39 | -10.32 % | $ 357 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
Grifols, S.A.
GRFS
|
14.1 | $ 8.57 | -1.44 % | $ 6.83 B | ||
|
Aquestive Therapeutics
AQST
|
-8.91 | $ 4.21 | -0.71 % | $ 450 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-612 | $ 23.86 | -2.93 % | $ 3.04 B | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.14 | $ 1.54 | 3.02 % | $ 410 M | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
Immatics N.V.
IMTX
|
-6.15 | $ 10.75 | -2.27 % | $ 676 M | ||
|
Checkpoint Therapeutics
CKPT
|
-5.15 | - | - | $ 169 M | ||
|
Incyte Corporation
INCY
|
13.8 | $ 95.06 | -2.11 % | $ 18.6 B | ||
|
Caladrius Biosciences
CLBS
|
-0.185 | - | -16.75 % | $ 25.8 M | ||
|
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
-5.59 | - | - | $ 25.3 M |